c-MET inhibitor Glesatinib hydrochloride, Purity ≥98%

Cat. No.: X24-06-ZQ049

c-MET inhibitor Glesatinib hydrochloride, Purity ≥98%

Synonym: 1123838-51-6; c-MET inhibitor; MGCD265 hydrochloride; MGCD-265 hydrochloride; MGCD 265 hydrochloride

  • CAS Number: 1123838-51-6
  • Compound CID: 127255607
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
Glesatinib hydrochloride inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis.
Molecular Weight
655.16
Molecular Formula
C31H27ClF2N5O3S2X
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Glesatinib hydrochloride is utilized in research to inhibit c-MET, a tyrosine kinase receptor involved in tumor cell proliferation and metastasis.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0